Yuanyin Bio focuses on the research and application of circular RNA technology.
Yuanyin Bio is a biotechnology company focuses on the research and application of circular RNA technology in the field of innovative drugs and therapies, builds a robust pipeline of preventive and therapeutic new drugs, and is dedicated to addressing clinically unmet disease needs. They serve in the field of innovative drugs and therapies. It establishes a pipeline of preventive and therapeutic new drugs and is committed to solving clinically unmet disease needs.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 20, 2022 | Series A | ¥280M | 6 |
MSA Capital
|
— | Detail |
| Nov 29, 2021 | Seed | ¥100M | 2 |
Quan Capital
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
MSA Capital
|
Yes | Series A |
3H Health Investment
|
— | Series A |
Cenova
|
— | Series A |
Quan Capital
|
— | Series A |
|
|
— | Series A |
Tencent
|
— | Series A |